Related Experiment Video
Updated: Apr 30, 2026

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia
Published on: January 19, 2022
Diagnosis and management of primary ciliary dyskinesia
Jane S Lucas1, Andrea Burgess2, Hannah M Mitchison3
1Primary Ciliary Dyskinesia Centre, Southampton Children's Hospital, Southampton NHS Foundation Trust, Southampton, UK Clinical and Experimental Sciences Academic Unit, University of Southampton Faculty of Medicine, Southampton, UK.
Insights
Primary ciliary dyskinesia (PCD) is a genetic disorder affecting motile cilia, causing chronic respiratory issues and other health problems. This review discusses diagnostic challenges and future genetic testing for PCD patients.
Area of Science:
- Genetics
- Pulmonology
- Otolaryngology
Background:
- Primary ciliary dyskinesia (PCD) is an inherited autosomal-recessive disorder affecting motile cilia.
- It leads to chronic lung disease, rhinosinusitis, hearing impairment, subfertility, and often bronchiectasis by adulthood.
- Organ laterality defects, such as situs inversus, occur in approximately 50% of cases.
Purpose of the Study:
- To review current diagnostic testing referrals for Primary ciliary dyskinesia (PCD).
- To discuss limitations of existing diagnostic techniques for PCD.
- To explore the potential of genetic testing and screening for future PCD diagnosis and management.
Main Methods:
- Literature review of diagnostic criteria and current practices for PCD.
- Analysis of recent advances in genetic research related to PCD.
- Discussion of clinical challenges in managing PCD-related respiratory and ENT conditions.
Main Results:
- Current diagnostic methods for PCD have limitations.
- Genetic testing holds promise for improving PCD diagnosis and screening.
- Effective monitoring and treatment of respiratory and ENT issues in children with PCD remain challenging.
Conclusions:
- Referral for PCD diagnostic testing should be considered in individuals with characteristic symptoms.
- Advances in genetic analysis may soon facilitate more accurate and widespread PCD diagnosis.
- Integrated management strategies are crucial for addressing the multifaceted health impacts of PCD in children.
Abstract:
Primary ciliary dyskinesia (PCD) is an inherited autosomal-recessive disorder of motile cilia characterised by chronic lung disease, rhinosinusitis, hearing impairment and subfertility. Nasal symptoms and respiratory distress usually start soon after birth, and by adulthood bronchiectasis is invariable. Organ laterality defects, usually situs inversus, occur in ∼50% of cases. The estimated prevalence of PCD is up to ∼1 per 10,000 births, but it is more common in populations where consanguinity is common. This review examines who to refer for diagnostic testing. It describes the limitations surrounding diagnosis using currently available techniques and considers whether recent advances to genotype patients with PCD will lead to genetic testing and screening to aid diagnosis in the near future. It discusses the challenges of monitoring and treating respiratory and ENT disease in children with PCD.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-I: Introduction
COPD: Management Using Bronchodilators and Corticosteroids
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment

